Dr. Susan Trieu sits down with Specialty Pharmacy Continuum to discuss what's ahead for the specialty drug market this year.
2023 was a landmark year for specialty drugs - for R&D and new FDA approvals. Dr. Susan Trieu, our head of specialty clinical strategy, is closely following the trends. She recently shared a forecast in a video interview with Specialty Pharmacy Continuum.
The takeaway? Specialty pharmacy growth is here to stay.
"Research and development in the pharmaceutical space and specialty has been a hot topic for a long time because of the cost of specialty medications. Although a small percentage of the actual population uses a specialty drug, it is accounting for over 50% of actual healthcare spend."
"Although a small percentage of the population uses a specialty drug, it is accounting for over 50% of actual healthcare spend."
Watch the full interview at the link below.